Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation

Bibliographic Details
Main Authors:	Shady Adnan Awad, Oscar Brück, Naranie Shanmuganathan, Timo Jarvinen, Hanna Lähteenmäki, Jay Klievink, Hazem Ibrahim, Soili Kytölä, Perttu Koskenvesa, Timothy P. Hughes, Susan Branford, Matti Kankainen, Satu Mustjoki
Format:	Article
Language:	English
Published:	Nature Publishing Group 2022-04-01
Series:	Blood Cancer Journal
Online Access:	https://doi.org/10.1038/s41408-022-00667-9

Internet